SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
TELK -- Telik, Inc.
An SI Board Since October 2000
Posts SubjectMarks Bans Symbol
887 37 0 TELK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
362biotech's second law, as formulated by Erik, on the Valuation thread - <nigel bates-4/14/2003
361There is also the lesser known <b>Corollary to Hofstadter's Law:</bBiomaven-4/14/2003
360I believe biotech projects are subject to a law formulated for computer projectsDoc Bones-4/11/2003
359Telik Announces Drug Discovery Collaboration With Roche PALO ALTO, Calif., Aprinigel bates-4/10/2003
358<i>Where are those leads? How many milestones did they trigger?</i> nigel bates-4/10/2003
357Remember back in the old days, where TRAP was successful in identifying leads foscaram(o)uche-4/9/2003
356That wouldn't surprise me; interim data from the first patients enrolled. Ytuck-4/9/2003
355Word is, it is based on 8 of the 12 patients enrolled.mopgcw-4/9/2003
354>>PALO ALTO, Calif., April 9 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaqtuck-4/9/2003
353Wachovia's take: TELK: Initiates Pivotal Study Of TLK286 In Ovarian Cancer mopgcw-4/8/2003
352So far I am not impressed with TLK-16998. Have no idea how is L7 doing. This daMiljenko Zuanic-3/27/2003
351I read the article comparing tlk16998 and mrk's L7 in insulin resistant cellkeokalani'nui-3/27/2003
350>>9:38AM Legg Mason reiterates Buy rating on Telik following announcement tuck-3/27/2003
349This spanking new abstract makes me wonder: note Villar among the authors, but htuck-2/20/2003
348Merrill starts coverage at neutral.mopgcw-2/14/2003
347SOUTH SAN FRANCISCO, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdnigel bates-2/12/2003
346>>8:53AM Telik upgraded at Fulcrum (TELK) 12.25: Fulcrum upgrades to Buy ftuck-1/23/2003
345What a joke of the analyst/broker house!Miljenko Zuanic-1/16/2003
344Briefing: Telik upped to Overweight at Lehman (12.94 +0.84) Lehman upgrades totom pope-1/16/2003
343Still not a shareholder, but..... that molecule that ETRX got with Maret, thescaram(o)uche-1/6/2003
342Needham maintains SB w/ $26 targetmopgcw-1/2/2003
341>>SOUTH SAN FRANCISCO, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Telik, Intuck-12/17/2002
340SOUTH SAN FRANCISCO, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdanigel bates-12/9/2002
339I didn't say that the call was good or bad. I'm just saying that, in spscaram(o)uche-11/21/2002
338but the market did not seem to take to the colorectal data...mopgcw-11/21/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News